Investigators hope leading-edge scientific studies will translate into therapies for difficult-to-treat skeletal muscle disorders, as well as heart muscle damage
A Sept. 16 scientific program will be held in remembrance of Dr. George Stamatoyannopoulos to discuss cell and gene therapy, and other fields of his interest. .
The next-generation versions of the micro-dystrophins made muscles stronger while avoiding contraction injuries in an animal model of the disease
For the past eight years, Childers has been focused on finding a cure for a form of muscular dystrophy called Myotubular Myopathy or MTM. It is a rare disease that affects the skeletal muscles.
A therapy developed at UW shows promise in its first test in young boys who have an inherited deady muscle disease.
Download video (broadcast and web versions) of Drs.
Within months, clinical trials of a gene therapy will begin with a small group of children affected with a deadly muscle-wasting disease.
For Immediate Release:
Media contact: Leila Gray, 206.685.0381, email@example.com
A newly established muscular dystrophy research center in Seattle hopes to bring promising laboratory results into therapeutic trials.
The UW's teaching program for bioethics is recognized as one of the nation's most vibrant and comprehensive such collection of courses. UW Medicine writer Brian Donohue spoke with several instructors to generate a seven-part series of Q&As.